White House Announces New COVID Vaccination and Testing Requirements for Contractors Working at Federal Facilities
Client Alert | 1 min read | 07.30.21
On July 29, 2021, President Biden announced certain actions to “get more people vaccinated.” The White House announced that “every federal government employee and onsite contractor will be asked to attest to their vaccination status. Anyone who does not attest to being fully vaccinated will be required to wear a mask on the job no matter their geographic location, physically distance from all other employees and visitors, comply with a weekly or twice weekly screening testing requirement, and be subject to restrictions on official travel.” The White House also said that “these rules should not only apply to federal workers and onsite contractors. President Biden is directing his team to take steps to apply similar standards to all federal contractors.” In his remarks on July 29, the President said “If you want to do business with the federal government, get your workers vaccinated.” The Safer Federal Workforce Task Force – an interagency task force that is part of the White House COVID-19 Response Team – released model safety principles to reflect the July 29 announcement from President Biden. The model principles, which will need to be implemented on an agency-by-agency basis, require federal agencies “to ask about the vaccination status of Federal employees and onsite contractors—employees and onsite contractors must sign an attestation confirming their vaccination status, or they will be treated as not fully vaccinated for purposes of safety protocols. Federal agencies also must establish a program to test not fully vaccinated Federal employees and onsite contractors weekly or twice-weekly.” Because each agency has discretion to implement agency-specific procedures, federal contractors may be subject to varying requirements across the agencies with which they contract. The requirements for federal contractors continue to evolve and many employers may have questions the practical and legal implications of yesterday’s announcement and the forthcoming implementation. The Crowell team will be tracking developments closely and is standing by to answer your questions.
Contacts
Insights
Client Alert | 6 min read | 04.29.26
CMS Seeks to Expand Interoperability Requirements to Drug Pre-Authorization (FAQ)
On April 10, 2026, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule (2026 CMS Interoperability Standards and Prior Authorization for Drugs, or CMS-0062-P) outlining the agency’s plans to impose new interoperability requirements on payors participating in certain Medicare and Medicaid programs. As described by the agency in a recent press release, the proposed rule “builds on” prior rulemaking by clarifying and enhancing interoperability requirements for payors’ prior authorization processes, specifically those associated with coverage requests for pharmaceutical therapies.
Client Alert | 8 min read | 04.27.26
Client Alert | 5 min read | 04.27.26
Drift Protocol Exploit: Why “Social Trust” Is the Newest Cybersecurity Gap
Client Alert | 4 min read | 04.27.26
Gaming Addiction Litigation: Turner v. Epic Games & Roblox and What It Means for the Industry







